Patents by Inventor Christopher Brook

Christopher Brook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210155637
    Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.
    Type: Application
    Filed: November 24, 2020
    Publication date: May 27, 2021
    Inventors: Teresa De Haro Garcia, Michael Deligny, Jag Paul Heer, Joanna Rachel Quincey, Mengyang Xuan, Zhaoning Zhu, Daniel Christopher Brookings, Mark Daniel Calmiano, Yves Evrard, Martin Clive Hutchings, James Andrew Johnson, Sophie Jadot, Jean Keyaerts, Malcolm Mac Coss, Matthew Duncan Selby, Michael Alan Shaw, Dominique Louis Leon Swinnen, Laurent Schio, Yann Foricher, Bruno Filoche-Romme
  • Publication number: 20210151755
    Abstract: The invention generally relates to electrochemically active structures and methods of making thereof. More specifically, the invention relates to electrochemically active structure comprising a crystalline electride comprising a nitride or carbide of at least one of: an alkaline earth metal, a transition metal, a lanthanide metal, or a combination thereof, wherein the electride has a lattice capable of intercalating at least one ion, thereby releasing at least one electron into an external circuit; and wherein a change in lattice volume of the electride upon intercalating the at least one ion is less than about 40%. Further, methods of making these electrochemically active structures are disclosed. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: November 18, 2020
    Publication date: May 20, 2021
    Inventors: Scott C. Warren, Daniel L. Druffel, Jacob Pawlik, Adam H. Woomer, Qingmin Xu, Kaoru Omichi, Christopher Brooks
  • Patent number: 10980814
    Abstract: Disclosed herein are compounds of formula (I) and pharmaceutically acceptable salt thereof, wherein variables X, R1, R2, and R3 are defined herein. These compounds are potent modulators of human TNF? activity and, accordingly, of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: April 20, 2021
    Assignees: UCB Biopharma SRL, Sanofi
    Inventors: Daniel Christopher Brookings, Teresa De Haro Garcia, Yann Foricher, Helen Tracey Horsley, Martin Clive Hutchings, James Andrew Johnson, Malcolm Maccoss, Mengyang Xuan, Zhaoning Zhu
  • Publication number: 20210103266
    Abstract: Disclosed herein is a method of repairing a component. The method includes scanning a damaged area of the component, and preparing a repair plan in response to the scanning. The method may also include providing the repair plan to a guided tool having a position correcting controller, and removing damaged material from the component in preparation for a repair operation. An apparatus is also disclosed that includes a computing device configured for performing actions. The computing device includes a processor and a local memory. The actions include detecting damage to the component, recording position information of the detected damage, and incorporating the position information in the repair plan.
    Type: Application
    Filed: October 7, 2019
    Publication date: April 8, 2021
    Inventors: Christopher Brooks, JR., Phillip Crothers
  • Publication number: 20210093701
    Abstract: Provided herein are cancer stem cell targeted cancer vaccines and methods for treating and vaccinating against cancer. Also contained herein are regimens by which cancer stem cell targeted cancer vaccines are administered, such regimens comprising peptides, compositions, immunomodulatory agents, and emulsifiers. Also provided are the patient populations to which the regimens are to be administered, and the dosages, schedules, route of administration for the regimens.
    Type: Application
    Filed: October 10, 2019
    Publication date: April 1, 2021
    Applicant: Stemline Therapeutics, Inc.
    Inventors: Ivan Bergstein, Christopher Brooks, Thomas P. Cirrito
  • Patent number: 10953019
    Abstract: A series of substituted fused pentacyclic imidazopyridine and imidazopyridazine derivatives, and analogues thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: March 23, 2021
    Assignees: UCB Biopharma SRL, Sanofi
    Inventors: Julien Alistair Brown, Daniel Christopher Brookings, Jag Paul Heer, James Andrew Johnson, Zhaoning Zhu
  • Patent number: 10950893
    Abstract: The present disclosure relates to an electrochemical cell which may be used, for example, in a rechargeable battery based on the reversible transfer of halide anions, and a method for making an electrolyte composition for use in the same. The electrochemical cell includes a positive electrode, a negative electrode, and an electrolyte composition positioned between the two electrodes, where the electrolyte composition contains a crown ether-metal halide complex in a solvent.
    Type: Grant
    Filed: January 31, 2017
    Date of Patent: March 16, 2021
    Assignee: HONDA MOTOR CO., LTD.
    Inventors: Kaoru Omichi, Christopher Brooks, Ryan McKenney
  • Publication number: 20210052585
    Abstract: The present invention includes substituted 3,3?bis(phenoxymethyl)-1,1?-biphenyl compounds, analogues thereof, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) and/or hepatitis D virus (HDV) infections in a patient.
    Type: Application
    Filed: March 29, 2019
    Publication date: February 25, 2021
    Inventors: Yingzhi Bi, Bruce D. Dorsey, Yi Fan, Christopher Brooks Moore, Duyan Nguyen
  • Patent number: 10906919
    Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: February 2, 2021
    Assignees: UCB Biopharma SRL, Sanofi
    Inventors: Teresa De Haro Garcia, Michael Deligny, Jag Paul Heer, Joanna Rachel Quincey, Mengyang Xuan, Zhaoning Zhu, Daniel Christopher Brookings, Mark Daniel Calmiano, Yves Evrard, Martin Clive Hutchings, James Andrew Johnson, Sophie Jadot, Jean Keyaerts, Malcolm Mac Coss, Matthew Duncan Selby, Michael Alan Shaw, Dominique Louis Leon Swinnen, Laurent Schio, Yann Foricher, Bruno Filoche-Romme
  • Patent number: 10883996
    Abstract: The invention is in the field of TNF signalling. Compounds have been identified which are capable of modulating signalling of TNF trimers through receptors. Methods of identifying such compounds are therefore provided. The compounds themselves have utility in therapy.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: January 5, 2021
    Assignee: UCB BIOPHARMA SRL
    Inventors: James Philip O'Connell, John Robert Porter, Alastair Lawson, Boris Kroeplien, Stephen Edward Rapecki, Timothy John Norman, David James McMillan, Graham John Warrellow, Daniel Christopher Brookings, Rikki Peter Alexander
  • Publication number: 20200335788
    Abstract: An anode for a fluoride ion electrochemical cell is provided and includes a layered material of hard carbon, nitrogen doped graphite, boron doped graphite, TiS2, MoS2, TiSe2, MoSe2, VS2, VSe2, electrides of alkali earth metal nitrides, electrides of metal carbides, or combinations thereof. The anode may be included in a fluoride ion electrochemical cell, which additionally includes a cathode and a fluoride ion electrolyte arranged between the cathode and the anode. At least one of the cathode and the anode reversibly exchange the fluoride ions with the electrolyte during charging or discharging of the electrochemical cell.
    Type: Application
    Filed: June 30, 2020
    Publication date: October 22, 2020
    Inventors: Kaoru Omichi, Qingmin Xu, Christopher Brooks
  • Patent number: 10791851
    Abstract: An accessory shelf rail system includes a generally planar top portion, a generally planar front portion, a lower portion of the front portion angled inwardly, a rear portion of the top portion including a top channel and a lip forming a lip channel, the top channel and the lip channel are contained in an entire length of the top portion, and a step-shaped securing bracket slidably positioned in the lip channel, the step-shaped securing bracket configured to removably attach the top portion to a horizontal retail shelf.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: October 6, 2020
    Assignee: PLASTICS PLUS, INC
    Inventors: Daniel Zussman, Christopher Brooks
  • Patent number: 10788963
    Abstract: Techniques for recording and replay of a live conference while still attending the live conference are described. A conferencing system includes a user interface generator, a live conference processing module, and a replay processing module. The user interface generator is configured to generate a user interface that includes a replay control panel and one or more output panels. The live conference processing module is configured to extract information included in received conferencing data that is associated with one or more conferencing modalities, and to display the information in the one or more output panels in a live manner (e.g., as a live conference). The replay processing module is configured to enable information associated with the one or more conferencing modalities corresponding to a time of the conference session prior to live to be presented at a desired rate, possibly different from the real-time rate.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: September 29, 2020
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Kori Inkpen Quinn, Rajesh Hedge, Zhengyou Zhang, John Tang, Sasa Junuzovic, Christopher Brooks
  • Patent number: 10788065
    Abstract: A panel assembly that is configured to be secured to a frame that includes a panel having a top and a bottom, a first bracket assembly and a second bracket assembly. The first bracket assembly includes a first pivot member and a first bracket. One of the first bracket and first pivot member is secured to the panel and the other is configured to be secured to the frame. The first bracket includes a slot defined therein that includes a throat and a pivot opening. The throat is defined between first and second throat surfaces and the throat is narrower than the pivot opening. The second bracket assembly includes a second pivot member and a second bracket. One of the second bracket and second pivot member is secured to the panel and the other is configured to be secured to the frame. The second bracket includes a pivot opening.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: September 29, 2020
    Assignee: C&D ZODIAC, INC.
    Inventors: Tyler Smithson, Jordan Thomas Payne, Tyson Dean Merrell, Stephen Michael Hills, Christopher Brooks, Matthew Bangerter, Michael D. Ridges
  • Patent number: 10727487
    Abstract: An anode for a fluoride ion electrochemical cell is provided and includes a layered material of hard carbon, nitrogen doped graphite, boron doped graphite, TiS2, MoS2, TiSe2, MoSe2, VS2, VSe2, electrides of alkali earth metal nitrides, electrides of metal carbides, or combinations thereof. The anode may be included in a fluoride ion electrochemical cell, which additionally includes a cathode and a fluoride ion electrolyte arranged between the cathode and the anode. At least one of the cathode and the anode reversibly exchange the fluoride ions with the electrolyte during charging or discharging of the electrochemical cell.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: July 28, 2020
    Assignee: Honda Motor Co., Ltd.
    Inventors: Kaoru Omichi, Qingmin Xu, Christopher Brooks
  • Patent number: 10720666
    Abstract: Electrolyte solutions including at least one anhydrous fluoride salt and at least one non-aqueous solvent are presented. The fluoride salt includes an organic cation having a charge center (e.g., N, P, S, or O) that does not possess a carbon in the ?-position or does not possess a carbon in the ?-position having a bound hydrogen. This salt structure facilitates its ability to be made anhydrous without decomposition. Example anhydrous fluoride salts include (2,2-dimethylpropyl)trimethylammonium fluoride and bis(2,2-dimethylpropyl)dimethylammonium fluoride. Combining these fluoride salts with at least one fluorine-containing non-aqueous solvent (e.g., bis(2,2,2-trifluoroethyl)ether; (BTFE)) promotes solubility of the salt within the non-aqueous solvents. The solvent may be a mixture of at least one non-aqueous, fluorine-containing solvent and at least one other non-aqueous, fluorine or non-fluorine containing solvent (e.g., BTFE and propionitrile or dimethoxyethane).
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: July 21, 2020
    Assignees: California Institute of Technology, Honda Motor Co., LTD.
    Inventors: Simon C. Jones, Victoria K. Davis, Christopher M. Bates, Nebojsa Momcilovic, Brett M. Savoie, Michael A. Webb, Thomas F. Miller, III, Robert H. Grubbs, Christopher Brooks, Kaoru Omichi
  • Publication number: 20200214475
    Abstract: An accessory shelf rail system includes a generally planar top portion, a generally planar front portion, a lower portion of the front portion angled inwardly, a rear portion of the top portion including a top channel and a lip forming a lip channel, the top channel and the lip channel are contained in an entire length of the top portion, and a step-shaped securing bracket slidably positioned in the lip channel, the step-shaped securing bracket configured to removably attach
    Type: Application
    Filed: February 21, 2020
    Publication date: July 9, 2020
    Inventors: Daniel Zussman, Christopher Brooks
  • Patent number: 10675681
    Abstract: Multifunctional core@shell nanoparticles (CSNs) useful in electrochemical cells, particularly for use as an electrocatalyst material. The multifunctional CSNs comprise a catalytic core component encompassed by one or more outer shells. Also included are electrochemical cell electrodes and electrochemical cells that electrochemically convert carbon dioxide to, for example, useful fuels (e.g., synthetic fuels) or other products, and which comprise multifunctional CSNs, and methods for making the same.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: June 9, 2020
    Assignee: HONDA MOTOR CO., LTD.
    Inventors: Nam Hawn Chou, Ryan McKenney, Christopher Brooks
  • Publication number: 20200165213
    Abstract: The present invention includes substituted 2,3-dihydro-1H-indene analogs, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient.
    Type: Application
    Filed: April 24, 2018
    Publication date: May 28, 2020
    Inventors: Yingzhi Bi, Bruce D. Dorsey, Christopher Brooks Moore
  • Publication number: 20200113354
    Abstract: An accessory shelf rail system includes a generally planar top portion, a generally planar front portion, a lower portion of the front portion angled inwardly, a rear portion of the top portion including a top channel and a lip forming a lip channel, the top channel and the lip channel are contained in an entire length of the top portion, and a step-shaped securing bracket slidably positioned in the lip channel, the step-shaped securing bracket configured to
    Type: Application
    Filed: December 6, 2019
    Publication date: April 16, 2020
    Inventors: Daniel Zussman, Christopher Brooks